Biden's Bold Move: Seizing Drug Patents to Combat High Prices

Republican lawmakers and economists have criticized President Biden's proposal to seize patents from pharmaceutical companies that charge high prices for prescription drugs. The policy, part of Biden's "Bidenomics" agenda, targets drugs developed with taxpayer dollars and aims to lower prices. GOP lawmakers argue that Biden does not have the legal authority to seize drug patents and that the policy will stifle innovation and harm Americans. Economists question Biden's claim of insufficient competition in the drug market and suggest exploring other avenues to promote competition. Critics warn that forcing companies to license their products could undermine drug innovation in the US.